Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2

A recent study from Sophie Valkenburg and Carolyn Cohen published in Nature Communications highlights significant differences in immune responses elicited by inactivated and mRNA vaccines against SARS-CoV-2. The research reveals that while both vaccine types provide protection from severe COVID-19, mRNA vaccines generate stronger antibody and T cell responses, suggesting enhanced effectiveness in combating variants like Omicron.

>>> Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2